lymphoma

Pick anything below and it plays in the bar at the foot of the window — and keeps playing while you go on browsing the directory.

1. 1▶Cost-Effectiveness of Current SCD Treatments and Potential Therapeutic Targets for Fetal HemoglobinopathiesBlood Podcast32:59Notes
   +Listen later
2. 2▶HLH-like toxicities after CAR-T and Structure-Function Relationships of FNAITBlood Podcast16:33Notes
   +Listen later
3. 3▶FLT3-ITD microclones in AML and Results from the RESET-PV trialBlood Podcast13:48Notes
   +Listen later
4. 4▶Initial CHORUS data on HHT and ASH HematOmics ProgramBlood Podcast26:14Notes
   +Listen later
5. 5▶IV Iron during Acute Infection and Revisiting iTTP RefractorinessBlood Podcast16:45Notes
   +Listen later
6. 6▶Waldenström macroglobulinemia: What to Know in PracticeTreating Blood Cancers36:03Notes
   +Listen later
7. 7▶A Pediatric ITP Risk Model and Targeting CD2 with CAR T-cell therapiesBlood Podcast18:17Notes
   +Listen later
8. 8▶IV Iron Risks and Low-Dose AML GainsBlood Podcast24:48Notes
   +Listen later
9. 9▶Mastocytosis: What Clinicians Need to KnowTreating Blood Cancers34:29Notes
   +Listen later
10. 10▶Orca-T for GVHD–free survival and Understanding VEXAS anemiaBlood Podcast23:04Notes
    +Listen later
11. 11▶Treating AML, Before and After RelapseBlood Podcast16:13Notes
    +Listen later
12. 12▶CAR-T Today and Tomorrow: Clinical Decision-Making and Patient SupportTreating Blood Cancers42:04Notes
    +Listen later
13. 13▶Future Directions in Relapsed and Refractory Large B-cell LymphomaBlood Podcast25:18Notes
    +Listen later
14. 14▶Optimizing HSCT in Blood CancersTreating Blood Cancers38:40Notes
    +Listen later
15. 15▶Clinical Strategies for Supporting Couples, Care Partners, and Families in Oncology CareTreating Blood Cancers35:22Notes
    +Listen later
16. 16▶Driving Progress in AMLTreating Blood Cancers34:20Notes
    +Listen later
17. 17▶Redefining Normal: Clinical Insights for Healthcare Professionals Supporting Survivors After TreatmentTreating Blood Cancers34:15Notes
    +Listen later
18. 18▶Optimizing Outcomes in MyelomaTreating Blood Cancers40:03Notes
    +Listen later
19. 19▶Strategies to Navigate Expanded Access (Compassionate Use) in Treating Pediatric OncologyTreating Blood Cancers39:55Notes
    +Listen later
20. 20▶What’s New and What’s Next in CLLTreating Blood Cancers39:19Notes
    +Listen later
21. 21▶Guiding Fertility Care for Adolescents and Young AdultsTreating Blood Cancers37:46Notes
    +Listen later
22. 22▶Building Resilience: Burnout & Compassion Fatigue Tools for HCPsTreating Blood Cancers36:41Notes
    +Listen later
23. 23▶Key Insights from Attending ASH 2025Treating Blood Cancers33:51Notes
    +Listen later
24. 24▶Delivering Equitable Cancer Care: What Every Healthcare Professional Should KnowTreating Blood Cancers30:48Notes
    +Listen later
25. 25▶Hairy Cell Leukemia: Strategies for Improved Patient OutcomesTreating Blood Cancers40:10Notes
    +Listen later
26. 26▶Managing CML: What HCPs Need to KnowTreating Blood Cancers37:19Notes
    +Listen later
27. 27▶Understanding MRD: Insights for clinical practice and patient careTreating Blood Cancers32:23Notes
    +Listen later
28. 28▶Pediatric Acute Leukemias: Focus on clinical trials for treatmentTreating Blood Cancers38:07Notes
    +Listen later
29. 29▶Charting the Course of ALL: From Diagnosis to AdvancesTreating Blood Cancers36:46Notes
    +Listen later
30. 30▶Strategies and Advances in AMLTreating Blood Cancers38:02Notes
    +Listen later
31. 31▶Advancing Care in Myeloproliferative Neoplasms (MPNs)Treating Blood Cancers32:51Notes
    +Listen later
32. 32▶A Collaborative Approach to Survivorship CareTreating Blood Cancers32:39Notes
    +Listen later
33. 33▶MDS: Patient-Centered Approaches to Diagnosis and TreatmentTreating Blood Cancers42:38Notes
    +Listen later
34. 34▶Optimizing Care for Pediatric Blood CancerTreating Blood Cancers39:57Notes
    +Listen later
35. 35▶Navigating Complex and Challenging Cases in MyelomaTreating Blood Cancers44:25Notes
    +Listen later
36. 36▶Beyond Burnout: Strategies for Empowering Healthcare ProfessionalsTreating Blood Cancers33:23Notes
    +Listen later
37. 37▶Key Strategies for HCPs: Supporting Caregivers and Care PartnersTreating Blood Cancers30:43Notes
    +Listen later
38. 38▶CAR-T in 2025: Advancements and the Road AheadTreating Blood Cancers38:12Notes
    +Listen later
39. 39▶Exploring Cutaneous T-Cell LymphomaTreating Blood Cancers32:08Notes
    +Listen later
40. 40▶Highlights from Attending ASH 2024Treating Blood Cancers51:17Notes
    +Listen later
41. 41▶Advancing Treatment Strategies: The Role of Bispecific Antibodies in LymphomaTreating Blood Cancers26:25Notes
    +Listen later
42. 42▶Understanding Mental Health in Cancer SurvivorshipTreating Blood Cancers26:34Notes
    +Listen later
43. 43▶What’s New in Chronic Lymphocytic Leukemia (CLL)?Treating Blood Cancers34:32Notes
    +Listen later
44. 44▶The Role of the Healthcare Team in Biomarker TestingTreating Blood Cancers30:16Notes
    +Listen later
45. 45▶Decoding Medicare for Healthcare ProfessionalsTreating Blood Cancers35:19Notes
    +Listen later
46. 46▶Treating Hodgkin Lymphoma: What HCPs Need to KnowTreating Blood Cancers31:53Notes
    +Listen later
47. 47▶Highlights from Attending the 2024 Society of Hematologic Oncology (SOHO) Annual MeetingTreating Blood Cancers25:33Notes
    +Listen later
48. 48▶Unpacking Mantle Cell LymphomaTreating Blood Cancers33:36Notes
    +Listen later
49. 49▶Clinical Perspectives on Hereditary Myeloid and Hematologic DisordersTreating Blood Cancers25:12Notes
    +Listen later
50. 50▶Navigating Adult Survivorship CareTreating Blood Cancers23:37Notes
    +Listen later